Sun Li

Aligos Therapeutics Announces Research Collaboration and Development Agreement with Xiamen Amoytop Biotech Co. Ltd. for Use of Aligos’ Oligonucleotide Platform for the Treatment of Liver Diseases

Retrieved on: 
Friday, May 12, 2023

Under the terms of the agreement, Aligos and Amoytop will collaborate on the research and development of oligonucleotide compounds for the treatment of liver diseases.

Key Points: 
  • Under the terms of the agreement, Aligos and Amoytop will collaborate on the research and development of oligonucleotide compounds for the treatment of liver diseases.
  • Amoytop will receive an option to obtain an exclusive license to develop and commercialize the resultant products in the Greater China territory while Aligos will retain rest-of-world rights.
  • “We are pleased to begin our collaboration with Amoytop, a leading Chinese domestic pharmaceutical company developing innovative therapies for liver diseases,” said Lawrence Blatt, Ph.D., MBA, Chairman & CEO of Aligos.
  • We look forward to working together to advance new treatment options for patients in need.”

iQIYI's The Ideal City Becomes Instant Hit in First Week on Air

Retrieved on: 
Tuesday, August 24, 2021

Enthusiasm only increased as the series aired - hashtags for the show on China's Twitter-like social media platform Weibo was viewed over 1 billion as of August 23.

Key Points: 
  • Enthusiasm only increased as the series aired - hashtags for the show on China's Twitter-like social media platform Weibo was viewed over 1 billion as of August 23.
  • The dramadepicts the journeys of young architects, striving to forge their own paths in the workplace.
  • Chao has won the Huabiao Film Award and the Huading Award and was nominated for the Magnolia Award for Best Actor.
  • China's burgeoning film and television industriesshow strong demand for original content that features realistic themes, creative depictions, and diverse voices.